HomeONC • TSE
add
Oncolytics Biotech Inc
Nakaraang pagsara
$0.77
Sakop ng taon
$0.67 - $2.08
Market cap
61.62M CAD
Average na Volume
57.97K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 8.44M | -4.66% |
Net na kita | -8.02M | -103.01% |
Net profit margin | — | — |
Kita sa bawat share | -0.10 | 9.91% |
EBITDA | -8.43M | 4.56% |
Aktuwal na % ng binabayarang buwis | -0.29% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 15.94M | -54.34% |
Kabuuang asset | 20.19M | -48.00% |
Kabuuang sagutin | 14.20M | 26.18% |
Kabuuang equity | 5.98M | — |
Natitirang share | 86.42M | — |
Presyo para makapag-book | 11.00 | — |
Return on assets | -94.91% | — |
Return on capital | -245.72% | — |
Cash Flow
Net change in cash
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -8.02M | -103.01% |
Cash mula sa mga operasyon | -7.85M | -28.12% |
Cash mula sa pag-invest | -6.00K | -100.00% |
Cash mula sa financing | 3.34M | 91.68% |
Net change in cash | -3.66M | 27.88% |
Malayang cash flow | -4.62M | 44.28% |
Tungkol
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Itinatag
1998
Headquarters
Website
Mga Empleyado
28
